High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 5, 1998, Pages 1033-1039

  MacLeod, Craig ^a   Fowler, Allan ^a   Duval, Peter ^c   D'Costa, Ieta ^d   Dalrymple, Chris ^b   Firth, Ian ^a   Elliott, Peter ^b   Atkinson, Ken ^b   Carter, Jonathan ^b  

^a Department of Radiation Oncology ^*  (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Brachytherapy; Endometrial cancer; High dose rate

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE COST; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; TREATMENT OUTCOME; VAGINA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 0032437609     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00292-2     Document Type: Article

References (33)

1. Aalders J, Abeler V, Kolstad P; et al. Postoperative external irradiation and prognostic parameters in stage I endometrial cancer. Obstet Gynecol 56:419-426.
2. Orr J.W., Holiman J.L., Orr P.F. Stage I corpus cancer: Is teletherapy necessary? Am J Obstet Gynecol. 76:1997;777-787.
3. Joslin C.A., Vaishampayan G.V., Mallik A. The treatment of early cancer of the corpus uteri. Br J Radiol. 50:1977;38-45.
4. Sorbe B.G., Smeds A.C. Post-operative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys. 18:1990;305-314.
5. Mandell L.M., Nori D., Anderson L.L., et al. Post-operative vaginal radiation in endometrial cancer using a remote afterloading technique. Int J Radiat Oncol Biol Phys. 11:1985;473-478.
6. Nori D., Merimsky O., Batata M., et al. Postoperative high dose rate brachytherapy combined with external irradiation for early stage endometrial cancer: A long term follow-up. Int J Radiat Oncol Biol Phys. 30:1994;831-837.
7. Fanning J., Nanavati P.J., Hilgers R.D. Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherpay to node-positive patients. Obstet Gynecol. 6:1996;1041-1044.
8. Gumbs AA, Turner BC, Knisely JPS; et al. Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma. (Abstr.) 38th ASTRO Proceedings 2101. Int J Radiat Oncol Biol Phys 1996; 36:327.
9. Noyes W.R., Bastion K., Edwards S.A., et al. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: A phase II clinical protocol. Int J Radiat Oncol Biol Phys. 32:1995;1439-1443.
10. Carey M.S., O'Connell G.J., Johanson C.R., et al. Good outcome associated with a standardized protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 57:1995;138-144.
11. Konski A.A., Bracy P.M., Jurs S.C., et al. Cost minimization analysis of various treatment options for surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys. 37:1997;367-372.
12. Berlinson J.L., Lee K.R., Badger G.L., et al. Clinical stage I adenocarcinoma of the endometrium - analysis of recurrences and potential benefits of staging lymphadenectomy. Gynecol Oncol. 44:1992;17-23.
13. Rush S., Gal D., Potters L., et al. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys. 33:1995;851-854.
14. Elliot P., Green D., Coates A., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int Gynecol Cancer. 4:1994;84-93.
15. Creaseman W.T., Morrow C.P., Bundy B.N., et al. Surgical pathological spread patterns of endometrial cancer. A GOG study. Cancer. 60:1987;2035-2041.
16. Zaino R.J., Kurman R.J., Diana K.L., et al. Pathological models to predict outcome for women with endometrial cancer. The importance of the distinction between surgical stage and clinical stage - a GOG study. Cancer. 77:1996;1115-1121.
17. Bond W.H. Early uterine body carcinoma: Has post operative vaginal radiation therapy any value? Clin Radiol. 36:1985;619-623.
18. Graham J. The value of preoperative and post operative treatment by radium for carcinoma of the uterine body. Surg Gynecol Obstet. 132:1971;855-860.
19. Marchetti D.L., Piver M.S., Tsukada Y., et al. Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation. Obstet Gynecol. 67:1986;399-402.
20. Piver M.S., Hempling R.E. A prospective trial of post operative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation for grade 3 or deep myometrial invasion of stage I endometrial adenocarcinoma. Cancer. 66:1990;1133-1138.
21. Eltabbakh G.H., Piver M.S., Hempling R.E. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal lymph node sampling: Report of a prospective study. Int J Radiat Oncol Biol Phys. 38:1997;373-380.
22. Barendsen G.W. Dose fractionation dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
23. Fowler J.F. Brief summary of radiobiological princples in fractionated radiotherapy. Semin Radiat Oncol. 2:1992;16-21.
24. Yaes R.J., Pushpa P., Maruyama Y. On using the linear-quadratic model in daily practice. Int J Radiat Oncol Biol Phys. 20:1991;1353-1362.
25. Barton M. Tables of equivalent dose in 2Gy fractions: A simple application of the linear quadratic formula. Int J Radiat Oncol Biol Phys. 31:1995;371-378.
26. Lanciano R.M., Greven K.M. Adjuvant treatment for endometrial cancer: Who needs it? Gynecol Oncol. 57:1995;135-137.
27. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet. 339:1992;1-15.
28. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet. 339:1992;71-85.
29. Orton C.G. High dose rate versus low dose rate brachytherapy for gynecological cancer. Semin Radiat Oncol. 4:1993;232-239.
30. Orton C.G. Comparison of high dose rate versus low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
31. Bruner D.W., Lanciano R., Keegan R., et al. Vaginal stenosis and sexual functioning following intracavity radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 27:1993;825-830.
32. Bastion K., Buchler D., Stitt J., et al. Comparative cost analysis of high dose rate versus low dose rate brachytherapy for gynecological cancer. Am J Clin Oncol. 16:1993;256-263.
33. Chenery S.C.A., Pla M., Podgorsak E.B. Physical characteristics of the Selectron high dose rate intracavity afterloader. Br J Radiol. 58:1985;735-740.